Skip to main content
SpringerLink
Log in

Diabetic Nephropathy

  • Chapter
The Aging Kidney in Health and Disease

  • 1179 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. USRDS. USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2005.

    Google Scholar 

  2. Standards of medical care in diabetes—2006. Diabetes Care 2006; 29(Suppl 1): S4–42.

    Google Scholar 

  3. Caramori, M.L., Fioretto, P., Mauer, M. Enhancing the predictive value of urinary albumin for diabetic nephropathy. J. Am. Soc. Nephrol. 2006; 17(2):339–352.

    Article  PubMed  CAS  Google Scholar 

  4. Hovind, P., Tarnow, L., Rossing, P., et al. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: Inception cohort study. BMJ 2004; 328(7448):1105.

    Article  PubMed  Google Scholar 

  5. Mogensen, C.E., Christensen, C.K. Predicting diabetic nephropathy in insulin-dependent patients. N. Engl. J. Med. 1984; 311(2):89–93.

    Article  PubMed  CAS  Google Scholar 

  6. Tognoni, G. Report on management of renal failure in Europe, XXVI, 1995. A conceptual and practical framework for interactive use of the ERA-EDTA Registry. Nephrol. Dial. Transplant 1996;11(Suppl)7:1–3.

    PubMed  Google Scholar 

  7. Leon, C.A., Raij, L. Interaction of haemodynamic and metabolic pathways in the genesis of diabetic nephropathy. J. Hypertens. 2005; 23(11):1931–1937.

    Article  PubMed  CAS  Google Scholar 

  8. Lightstone, L., Rees, A.J., Tomson, C., Walls, J., Winearls, C.G., Feehally, J. High incidence of end-stage renal disease in Indo-Asians in the UK. Quar. J. Med. 1995; 88(3):191–195.

    CAS  Google Scholar 

  9. Rich, S.S. Genetics of diabetes and its complications. J. Am. Soc. Nephrol. 2006; 17(2):353–360.

    Google Scholar 

  10. Fioretto, P., Steffes, M.W., Barbosa, J., Rich, S.S., Miller, M.E., Mauer, M. Is diabetic nephropathy inherited? Studies of glomerular structure in type 1 diabetic sibling pairs. Diabetes 1999; 48(4):865–869.

    Article  PubMed  CAS  Google Scholar 

  11. Langefeld, C.D., Beck, S.R., Bowden, D.W., Rich, S.S., Wagenknecht, L.E., Freedman, B.I. Heritability of GFR and albuminuria in Caucasians with type 2 diabetes mellitus. Am. J. Kidney Dis. 2004; 43(5):796–800.

    Article  PubMed  Google Scholar 

  12. Susztak, K., Bottinger, E.P. Diabetic nephropathy: A frontier for personalized medicine. J. Am. Soc. Nephrol. 2006; 17(2):361–367.

    Article  PubMed  Google Scholar 

  13. Jones, S.L., Wiseman, M.J., Viberti, G.C. Glomerular hyperfiltration as a risk factor for diabetic nephropathy: Five-year report of a prospective study. Diabetologia 1991; 34(1):59–60.

    Article  PubMed  CAS  Google Scholar 

  14. Caramori, M.L., Fioretto, P., Mauer, M. Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: An indicator of more advanced glomerular lesions. Diabetes 2003; 52(4):1036–1040.

    Article  PubMed  CAS  Google Scholar 

  15. Klein, R., Zinman, B., Gardiner, R., et al. The relationship of diabetic retinopathy to preclinical diabetic glomerulopathy lesions in type 1 diabetic patients: The Renin-Angiotensin System Study. Diabetes 2005; 54(2):527–533.

    Article  PubMed  CAS  Google Scholar 

  16. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group. Kidney Int. 1995; 47(6):1703–1720.

    Google Scholar 

  17. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: The Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 2003; 290(16):2159–2567.

    Google Scholar 

  18. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352(9131):837–853.

    Google Scholar 

  19. Perkins, B.A., Ficociello, L.H., Silva, K.H., Finkelstein, D.M., Warram, J.H., Krolewski, A.S. Regression of microalbuminuria in type 1 diabetes. N. Engl. J. Med. 2003; 348(23):2285–2293.

    Article  PubMed  CAS  Google Scholar 

  20. Araki, S., Haneda, M., Sugimoto, T., et al. Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes. Diabetes 2005; 54(10):2983–2987.

    Article  PubMed  CAS  Google Scholar 

  21. Giorgino, F., Laviola, L., Cavallo Perin, P., Solnica, B., Fuller, J., Chaturvedi, N. Factors associated with progression to macroalbuminuria in microalbuminuric type 1 diabetic patients: The EURODIAB Prospective Complications Study. Diabetologia 2004; 47(6):1020–1028.

    Article  PubMed  CAS  Google Scholar 

  22. Lurbe, E., Redon, J., Kesani, A., et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N. Engl. J. Med. 2002; 347(11):797–805.

    Article  PubMed  CAS  Google Scholar 

  23. Nelson, R.G., Pettitt, D.J., Baird, H.R., et al. Pre-diabetic blood pressure predicts urinary albumin excretion after the onset of type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia 1993; 36(10):998–1001.

    Article  PubMed  CAS  Google Scholar 

  24. Chase, H.P., Garg, S.K., Marshall, G., et al. Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes. JAMA 1991; 265(5):614–617.

    Article  PubMed  CAS  Google Scholar 

  25. Baggio, B., Budakovic, A., Dalla Vestra, M., Saller, A., Bruseghin, M., Fioretto, P. Effects of cigarette smoking on glomerular structure and function in type 2 diabetic patients. J. Am. Soc. Nephrol. 2002; 13(11):2730–2736.

    Article  PubMed  CAS  Google Scholar 

  26. Lin, J., Hu, F.B., Rimm, E.B., Rifai, N., Curhan, G.C. The association of serum lipids and inflammatory biomarkers with renal function in men with type II diabetes mellitus. Kidney Int. 2006; 69(2):336–342.

    Article  PubMed  CAS  Google Scholar 

  27. Mogensen, C.E., Schmitz, A., Christensen, C.K. Comparative renal pathophysiology relevant to IDDM and NIDDM patients. Diabetes Metab. Rev. 1988; 4(5):453–483.

    PubMed  CAS  Google Scholar 

  28. Kramer, H.J., Nguyen, Q.D., Curhan, G., Hsu, C.Y. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA 2003; 289(24):3273–3277.

    Article  PubMed  Google Scholar 

  29. Eknoyan, G., Hostetter, T., Bakris, G.L., et al. Proteinuria and other markers of chronic kidney disease: A position statement of the National Kidney Foundation (NKF) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Am. J. Kidney Dis. 2003; 42(4):617–622.

    Article  PubMed  Google Scholar 

  30. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am. J. Kidney Dis. 2002; 39(2 Suppl 1):S1–266.

    Google Scholar 

  31. Striker LJS, G., D’ Agati, V. The Renal Biopsy, 3rd ed. Philadelphia: W.B. Saunders Company. 1997.

    Google Scholar 

  32. Brownlee, M. The pathobiology of diabetic complications: A unifying mechanism. Diabetes 2005; 54(6):1615–1625.

    Article  PubMed  CAS  Google Scholar 

  33. Ziyadeh, F.N., Sharma, K., Ericksen, M., Wolf, G. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J. Clin. Invest. 1994; 93(2):536–542.

    PubMed  CAS  Google Scholar 

  34. Williams, M.E., Tuttle, K.R. The next generation of diabetic nephropathy therapies: An update. Adv. Chronic Kidney Dis. 2005; 12(2):212–222.

    Article  PubMed  Google Scholar 

  35. Fornoni, A., Lenz, O., Striker, L.J., Striker, G.E. Glucose induces clonal selection and reversible dinucleotide repeat expansion in mesangial cells isolated from glomerulosclerosis-prone mice. Diabetes 2003; 52(10):2594–2602.

    Article  PubMed  CAS  Google Scholar 

  36. Gnudi, L., Viberti, G., Raij, L., et al. GLUT-1 overexpression: Link between hemodynamic and metabolic factors in glomerular injury? Hypertension 2003; 42(1):19–24.

    Article  PubMed  CAS  Google Scholar 

  37. Carmines, P.K., Ohishi, K., Ikenaga, H. Functional impairment of renal afferent arteriolar voltage-gated calcium channels in rats with diabetes mellitus. J. Clin. Invest. 1996; 98(11):2564–2571.

    Article  PubMed  CAS  Google Scholar 

  38. Galkina, E., Ley, K. Leukocyte recruitment and vascular injury in diabetic nephropathy. J. Am. Soc. Nephrol. 2006; 17(2):368–377.

    Article  PubMed  CAS  Google Scholar 

  39. Lewis, E.J., Hunsicker, L.G., Bain, R.P., Rohde, R.D. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N. Engl. J. Med. 1993; 329(20):1456–1462.

    Article  PubMed  CAS  Google Scholar 

  40. Bakris, G.L., Williams, M., Dworkin, L., et al. Preserving renal function in adults with hypertension and diabetes: A consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am. J. Kidney Dis. 2000; 36(3):646–661.

    PubMed  CAS  Google Scholar 

  41. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet 2000; 355(9200):253–259.

    Google Scholar 

  42. Parving, H.H., Lehnert, H., Brochner-Mortensen, J., Gomis, R., Andersen, S., Arner, P. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N. Engl. J. Med. 2001; 345(12):870–878.

    Article  PubMed  CAS  Google Scholar 

  43. Brenner, B.M., Cooper, M.E., de Zeeuw, D., et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N. Engl. J. Med. 2001; 345(12):861–869.

    Article  PubMed  CAS  Google Scholar 

  44. Lewis, E.J., Hunsicker, L.G., Clarke, W.R., et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N. Engl. J. Med. 2001; 345(12):851–860.

    Article  PubMed  CAS  Google Scholar 

  45. Hou, F.F., Zhang, X., Zhang, G.H., et al. Efficacy and safety of benazepril for advanced chronic renal insufficiency. N. Engl. J. Med. 2006; 354(2):131–140.

    Article  PubMed  CAS  Google Scholar 

  46. Barnett, A.H., Bain, S.C., Bouter, P., et al. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. N. Engl. J. Med. 2004; 351(19):1952–1961.

    Article  PubMed  CAS  Google Scholar 

  47. Chobanian, A.V., Bakris, G.L., Black, H.R., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42(6):1206–1252.

    Article  PubMed  CAS  Google Scholar 

  48. Ruggenenti, P., Fassi, A., Ilieva, A.P., et al. Preventing microalbuminuria in type 2 diabetes. N. Engl. J. Med. 2004; 351(19):1941–1951.

    Article  PubMed  CAS  Google Scholar 

  49. Gaede, P., Vedel, P., Larsen, N., Jensen, G.V., Parving, H.H., Pedersen, O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N. Engl. J. Med. 2003; 348(5):383–393.

    Article  PubMed  Google Scholar 

  50. Brown, A.F., Mangione, C.M., Saliba, D., Sarkisian, C.A. Guidelines for improving the care of the older person with diabetes mellitus. J. Am. Geriatr. Soc. 2003; 51(5 Suppl Guidelines):S265–280.

    Google Scholar 

  51. Wolfe, R.A., Port, F.K., Hawthorne, V.M., Guire, K.E. A comparison of survival among dialytic therapies of choice: In-center hemodialysis versus continuous ambulatory peritoneal dialysis at home. Am. J. Kidney Dis. 1990; 15(5):433–440.

    PubMed  CAS  Google Scholar 

  52. Held, P.J., Port, F.K., Turenne, M.N., Gaylin, D.S., Hamburger, R.J., Wolfe, R.A. Continuous ambulatory peritoneal dialysis and hemodialysis: Comparison of patient mortality with adjustment for comorbid conditions. Kidney Int. 1994; 45(4):1163–1169.

    Article  PubMed  CAS  Google Scholar 

  53. Vonesh, E.F., Snyder, J.J., Foley, R.N., Collins, A.J. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int. 2004; 66(6):2389–2401.

    Article  PubMed  Google Scholar 

  54. Brunner, F.P., Selwood, N.H. Profile of patients on RRT in Europe and death rates due to major causes of death groups. The EDTA Registration Committee. Kidney Int. Suppl. 1992; 38:S4–15.

    PubMed  CAS  Google Scholar 

  55. Konner, K., Hulbert-Shearon, T.E., Roys, E.C., Port, F.K. Tailoring the initial vascular access for dialysis patients. Kidney Int. 2002; 62(1):329–338.

    Article  PubMed  Google Scholar 

Download references

Authors
  1. Alessia Fornoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carlos Leon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Leopoldo Raij
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Departamento de Medicina, University of Salamanca, Salamanca, Spain

    Juan F. MachasNúñez M.D., Ph.D (Profesor Titular de Medicina) (Profesor Titular de Medicina)

  2. Guy’s King’s and St. Thomas’ School of Medicine King’s College, London, UK

    J. Stewart Cameron M.D., B.Sc., FRCP (Emeritus Professor of Renal Medicine) (Emeritus Professor of Renal Medicine)

  3. Toronto Western Hospital, Toronto, Ontario, Canada

    Dimitrios G. Oreopoulos M.D., Ph.D. (Professor of Medicine) (Professor of Medicine)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Fornoni, A., Leon, C., Raij, L. (2008). Diabetic Nephropathy. In: MachasNúñez, J.F., Cameron, J.S., Oreopoulos, D.G. (eds) The Aging Kidney in Health and Disease. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-72659-5_18

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-72659-5_18

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-72658-8

  • Online ISBN: 978-0-387-72659-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation